High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

about

Q57284280

sameAs

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

Item

http://www.wikidata.org/entity/Q57284267

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

High risk of tuberculosis duri ...... owel disease patients in India

@en

High risk of tuberculosis duri ...... owel disease patients in India

@nl

type

Item

label

High risk of tuberculosis duri ...... owel disease patients in India

@en

High risk of tuberculosis duri ...... owel disease patients in India

@nl

prefLabel

High risk of tuberculosis duri ...... owel disease patients in India

@en

High risk of tuberculosis duri ...... owel disease patients in India

@nl

P1476

High risk of tuberculosis duri ...... owel disease patients in India

@en

P2093

Ashish Agarwal

http://www.w3.org/2001/XMLSchema#string

Dawesh P Yadav

http://www.w3.org/2001/XMLSchema#string

Govind Makharia

http://www.w3.org/2001/XMLSchema#string

Rajan Dhingra

http://www.w3.org/2001/XMLSchema#string

Sandeep Goyal

http://www.w3.org/2001/XMLSchema#string

Saransh Jain

http://www.w3.org/2001/XMLSchema#string

Saurabh Kedia

http://www.w3.org/2001/XMLSchema#string

Sawan Bopanna

http://www.w3.org/2001/XMLSchema#string

Venigalla Pratap Mouli

http://www.w3.org/2001/XMLSchema#string

Vineet Ahuja

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

A simple clinical colitis activity index

Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation.

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.

Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study.

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.

Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.

P304

588-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5217/IR.2018.00023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30301331

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

Akafuba bulwadde

India

Tuberculosis in India

P932

6223459

http://www.w3.org/2001/XMLSchema#string

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

about

sameAs

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932